Search Results: open access
COSSA Members Advocate for Disabilities Treaty Ratification
In late July, the Senate Foreign Relations Committee voted 12-6 to move the United Nations Convention on the Rights of Persons with Disabilities on to the full Senate for ratification. The scientific community is mobilizing in support of the Convention, which, among other things, affirms statesâ responsibilities to ensure that persons with disabilities have equal opportunity to pursue and enjoy the benefits of scientific progress. COSSA endorsed a statement by the AAAS Board of Directors in support of ratification. In addition, several COSSA members are also urging the Senate to ratify the treaty: The American Statistical Association (ASA) released a…
AAAS Science and Human Rights Coalition Reflects on Five Years
The Science and Human Rights Coalition of the American Association for the Advancement of Science (AAAS) held its biannual meeting on July 14 and 15. COSSA is a member of the Coalition, which is a ânetwork of scientific and engineering membership organizations that recognize a role for scientists and engineers in human rights.â This year marks the fifth anniversary of the Coalitionâs founding, and the meeting provided an opportunity for members to look back on what has been accomplished and consider new directions for the future. An anniversary celebration is planned for October of this year.
COSSA Endorses AAAS Statement on Disabilities Treaty Ratification
COSSA has endorsed the statement of the American Association for the Advancement of Science (AAAS) Board of Directors urging the Senate to ratify the Convention on the Rights of Persons with Disabilities (CRPD). Adopted in 2006 by the United Nations General Assembly, the CRPD has been ratified by 146 countries. The U.S. was a signatory on the treaty, but previous attempts to ratify it in the Senate have failed. The Convention may again be brought to the Senate as early as this summer.
FDA Seeks Comments on its Strategic Priorities, 2014-2018
The Food and Drug Administration (FDA) is charged with âprotecting the public health by ensuring the safety, effectiveness, and security of human and veterinary drugs, biological products, and medical devices; ensuring the safety of foods, cosmetics, and radiation-emitting products; and regulating tobacco products.â Every four years, the FDA updates its Strategic Priorities document, which outlines the agency’s strategic intentions and plans for the years ahead. The agency is currently seeking comments to help it refine its Strategic Priorities FY 2014-2018.
- « Previous
- 1
- …
- 9
- 10
- 11